Last update 23 Jan 2025

Amlodipine Besylate/Lisinopril

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amlodipine/lisinopril, Lisonorm
Target
ACE x L-type calcium channel
Mechanism
ACE inhibitors(Angiotensin-converting enzyme inhibitors), L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers)
Therapeutic Areas
Cardiovascular Diseases
Active Indication
Essential HypertensionHypertension
Inactive Indication-
Originator Organization
Chemical Works of Gedeon Richter PlcChemical Works of Gedeon Richter Plc
Active Organization
Gedeon Richter Pharma GmbHChemical Works of Gedeon Richter PlcChemical Works of Gedeon Richter Plc
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
HU (08 Oct 2004),
Hypertension
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H31ClN2O8S
InChIKeyZPBWCRDSRKPIDG-UHFFFAOYSA-N
CAS Registry111470-99-6
View All Structures (2)

Related

1
Clinical Trials associated with Amlodipine Besylate/Lisinopril
EUCTR2005-005749-20-HU
/ Not yet recruitingNot ApplicableIIT
Amlodipint és lisinoprilt tartalmazó fix gyógyszerkombináció (Lisonorm®) hatásosságának és biztonságosságának vizsgálata essentialis hypertoniás betegeken (ALFESS) - ALFESS
100 Clinical Results associated with Amlodipine Besylate/Lisinopril
Login to view more data
100 Translational Medicine associated with Amlodipine Besylate/Lisinopril
Login to view more data
100 Patents (Medical) associated with Amlodipine Besylate/Lisinopril
Login to view more data
100 Deals associated with Amlodipine Besylate/Lisinopril
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
C09BB
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Essential Hypertension
HU
Chemical Works of Gedeon Richter PlcChemical Works of Gedeon Richter Plc
02 Feb 2009
Hypertension
HU
Gedeon Richter Pharma GmbH
08 Oct 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
ESH2019
Not Applicable
Hypertension
60
iuqhrhemso(pthfwxhlpy) = hrrrtcowst fmvnwccnip (zacwroistr )
View more
Positive
01 Jul 2019
hdginglgyg(qganitfvwo) = ieaplqbdad ucydpinpqj (cuvxlnwknn )
ESH2019
Not Applicable
Obesity | Hypertension
28
kybztfgnwi(jpetlrwwlb) = rhfuqbiecy ufusztczej (uranvyzigf )
View more
Positive
01 Jul 2019
Amlodipine 5 mg/Carvedilol 50 mg
mdrjngrvvk(vdywgfqwnj) = ieikzcxqxv pzyfkhoskl (ebhlfnthgz )
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free